These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17367582)

  • 1. Unified Huntington's disease rating scale: clinical practice and a critical approach.
    Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
    Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
    Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
    Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
    Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
    Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
    Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unified Huntington's disease rating scale: a follow up.
    Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
    Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of psychopathology in Huntington's disease: the critical role of caregivers.
    van Duijn E; Giltay EJ; Zitman FG; Roos RA; van der Mast RC
    J Nerv Ment Dis; 2010 May; 198(5):329-33. PubMed ID: 20458193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
    Fragassi NA; Stanzione M; Angelini R; Di Maio L
    Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex movement behaviour and progression of Huntington's disease.
    Andrich J; Saft C; Ostholt N; Müller T
    Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
    Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
    Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study using nabilone for symptomatic treatment in Huntington's disease.
    Curtis A; Mitchell I; Patel S; Ives N; Rickards H
    Mov Disord; 2009 Nov; 24(15):2254-9. PubMed ID: 19845035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of neuropathological severity in 100 patients with Huntington's disease.
    Rosenblatt A; Abbott MH; Gourley LM; Troncoso JC; Margolis RL; Brandt J; Ross CA
    Ann Neurol; 2003 Oct; 54(4):488-93. PubMed ID: 14520661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
    J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Huntington disease: clinical and genetic study in a Spanish population].
    Solís Pérez MP; Palau Martínez F; Burguera Hernández JA; Salazar Cifré A
    Neurologia; 1995 Nov; 10(9):362-6. PubMed ID: 8554791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness.
    Rao AK; Muratori L; Louis ED; Moskowitz CB; Marder KS
    Gait Posture; 2009 Apr; 29(3):433-6. PubMed ID: 19111470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological deterioration over time in patients with Huntington's disease.
    Lefaucheur JP; Ménard-Lefaucheur I; Maison P; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Mov Disord; 2006 Sep; 21(9):1350-4. PubMed ID: 16721731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
    Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
    Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
    Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.